In contrast, synovial sarcomas (SS) frequently exhibit overexpression of CDK2, CDK4, and MDM2, loss of CDKN2A, and mutations in genes such as CDK 4/6 [141]. The gene discussed is CDKN2A; the disease is synovial sarcoma.